Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/49450
Full metadata record
DC FieldValueLanguage
dc.contributor.authorvan der Bijl, P-
dc.contributor.authorSTASSEN, Jan-
dc.contributor.authorHaugaa, KH-
dc.contributor.authorEssayagh, B-
dc.contributor.authorBasso, C-
dc.contributor.authorThiene, G-
dc.contributor.authorFaletra, FF-
dc.contributor.authorEdvardsen, T-
dc.contributor.authorEnriquez-Sarano, M-
dc.contributor.authorNihoyannopoulos, P-
dc.contributor.authorMarsan, NA-
dc.contributor.authorChandrashekhar, YS-
dc.contributor.authorBax, JJ-
dc.date.accessioned2026-06-29T13:02:59Z-
dc.date.available2026-06-29T13:02:59Z-
dc.date.issued2024-
dc.date.submitted2026-06-29T12:47:22Z-
dc.identifier.citationJACC: Cardiovascular Imaging, 17 (10) , p. 1229 -1245-
dc.identifier.urihttp://hdl.handle.net/1942/49450-
dc.description.abstractMitral annular disjunction (MAD), a separation between the left atrium/mitral valve annulus and the left ventricular myocardium, is frequently seen in patients with arrhythmic mitral valve prolapse. Although an association exists between MAD and ventricular arrhythmias, little is known regarding the identification of individuals at high risk. Multimodality imaging including echocardiography, computed tomography, cardiac magnetic resonance, and positron emission tomography can play an important role in both the diagnosis and risk stratification of MAD. Due to a paucity of data, clinical decision making in a patient with MAD is challenging and remains largely empirical. Although MAD itself can be corrected surgically, the prevention and treatment of associated arrhythmias may require medical therapy, catheter ablation, and an implantable cardioverter-defibrillator. Prospective data are required to define the role of implantable cardioverter-defibrillators, targeted catheter ablation, and surgical correction in selected, at-risk patients.-
dc.description.sponsorshipThe Department of Cardiology of Leiden University Medical Center has received research grants from Abbott Vascular, Bayer, Biotronik, Bioventrix, Boston Scientific, Edwards Lifesciences, GE Healthcare and Medtronic. Dr Stassen has received grants from the European Society of Cardiology (Training Grant App000064741). Dr Haugaa has received grants from the Norwegian Research Council (ProCardio #309762, #288438, #298736). Dr Faletra has received speaker fees from Philips Healthcare. Dr Enriquez-Sarano has received consulting fees from Artivion, ChemImage, Edwards Lifesciences, and HighLife. Dr Marsan has received speaker fees from Abbott Vascular and GE Healthcare. Dr Bax has received speaker fees from Abbott Vascular. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE INC-
dc.rights2024 The authors. Published by Elsevier on behalf of the American College of Cardiology foundation. This is an open access article under the CC BY License ( http://creativecommons.org/licenses/by/4.0/ ).-
dc.subject.otherarrhythmias-
dc.subject.otherdisjunction-
dc.subject.otherimaging-
dc.subject.othermitral annular-
dc.subject.othermitral valve prolapse-
dc.titleMitral Annular Disjunction in the Context of Mitral Valve Prolapse Identifying the At-Risk Patient-
dc.typeJournal Contribution-
dc.identifier.epage1245-
dc.identifier.issue10-
dc.identifier.spage1229-
dc.identifier.volume17-
local.format.pages17-
local.bibliographicCitation.jcatA1-
local.publisher.placeSTE 800, 230 PARK AVE, NEW YORK, NY 10169-
local.type.refereedRefereed-
local.type.specifiedReview-
dc.identifier.doi10.1016/j.jcmg.2024.03.006-
dc.identifier.pmid38703174-
dc.identifier.isi001334641700001-
local.provider.typeWeb of Science-
local.uhasselt.internationalyes-
item.accessRightsOpen Access-
item.fullcitationvan der Bijl, P; STASSEN, Jan; Haugaa, KH; Essayagh, B; Basso, C; Thiene, G; Faletra, FF; Edvardsen, T; Enriquez-Sarano, M; Nihoyannopoulos, P; Marsan, NA; Chandrashekhar, YS & Bax, JJ (2024) Mitral Annular Disjunction in the Context of Mitral Valve Prolapse Identifying the At-Risk Patient. In: JACC: Cardiovascular Imaging, 17 (10) , p. 1229 -1245.-
item.fulltextWith Fulltext-
item.contributorvan der Bijl, P-
item.contributorSTASSEN, Jan-
item.contributorHaugaa, KH-
item.contributorEssayagh, B-
item.contributorBasso, C-
item.contributorThiene, G-
item.contributorFaletra, FF-
item.contributorEdvardsen, T-
item.contributorEnriquez-Sarano, M-
item.contributorNihoyannopoulos, P-
item.contributorMarsan, NA-
item.contributorChandrashekhar, YS-
item.contributorBax, JJ-
crisitem.journal.issn1936-878X-
crisitem.journal.eissn1876-7591-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
main.pdfPublished version2.55 MBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.